Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trialMehreen S. Datoo, Halidou Tinto, Daniel Valia et al.|The Lancet|2021Cited by 457
High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina FasoMehreen S. Datoo, Halidou Tinto, Hamtandi Magloire Natama et al.|SSRN Electronic Journal|2021Cited by 15
Subcutaneous administration of the malaria R21/Matrix M vaccine and immune complex formation with anti-circumsporozoite protein mAb 2A10 elicit protective efficacy in miceEkta Mukhopadhyay, Ahmed M. Salman|Frontiers in Immunology|2025Cited by 1